All news

HIV status does not influence Hodgkin's treatment outcomes

Added: Friday 12 October 2012

A retrospective analysis finds that HIV status has no impact on the outcomes of treatment for patients treated with ABVD for Hodgkin's lymphoma. This retrospective study compared outcomes of treatment with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) chemotherapy for HL in patients based on their HIV status.